Surveillance of infection severity: A registry study of laboratory diagnosed Clostridium difficile

Iryna Schlackow, A. Sarah Walker, Kate Dingle, David Griffiths, Sarah Oakley, John Finney, Ali Vaughan, Martin J. Gill, Derrick W. Crook, Tim E.A. Peto, David H. Wyllie

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Background: Changing clinical impact, as virulent clones replace less virulent ones, is a feature of many pathogenic bacterial species and can be difficult to detect. Consequently, innovative techniques monitoring infection severity are of potential clinical value. Methods and Findings: We studied 5,551 toxin-positive and 20,098 persistently toxin-negative patients tested for Clostridium difficile infection between February 1998 and July 2009 in a group of hospitals based in Oxford, UK, and investigated 28-day mortality and biomarkers of inflammation (blood neutrophil count, urea, and creatinine concentrations) collected at diagnosis using iterative sequential regression (ISR), a novel joinpoint-based regression technique suitable for serial monitoring of continuous or dichotomous outcomes. Among C. difficile toxin-positive patients in the Oxford hospitals, mean neutrophil counts on diagnosis increased from 2003, peaked in 2006-2007, and then declined; 28-day mortality increased from early 2006, peaked in late 2006-2007, and then declined. Molecular typing confirmed these changes were likely due to the ingress of the globally distributed severe C. difficile strain, ST1. We assessed the generalizability of ISR-based severity monitoring in three ways. First, we assessed and found strong (p<0.0001) associations between isolation of the ST1 severe strain and higher neutrophil counts at diagnosis in two unrelated large multi-centre studies, suggesting the technique described might be useful elsewhere. Second, we assessed and found similar trends in a second group of hospitals in Birmingham, UK, from which 5,399 cases were analysed. Third, we used simulation to assess the performance of this surveillance system given the ingress of future severe strains under a variety of assumptions. ISR-based severity monitoring allowed the detection of the severity change years earlier than mortality monitoring. Conclusions: Automated electronic systems providing early warning of the changing severity of infectious conditions can be established using routinely collected laboratory hospital data. In the settings studied here these systems have higher performance than those monitoring mortality, at least in C. difficile infection. Such systems could have wider applicability for monitoring infections presenting in hospital.

Original languageEnglish
Article numbere1001279
JournalPLoS Medicine
Issue number7
Publication statusPublished - Jul 2012

Bibliographical note

Funding Information:
IS was supported by NIHR grant RP-DG-1108-10125, and DW was supported in part by the Health Protection Agency during the work described. We declare no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years. IS, DW, TP, DC and ASW have applied for a patent related to the techniques described. TP has been a scientific advisor to Optimer Pharmaceuticals.


Dive into the research topics of 'Surveillance of infection severity: A registry study of laboratory diagnosed Clostridium difficile'. Together they form a unique fingerprint.

Cite this